Browsing Category
Pharma Industry News
4741 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Eli Lilly wins European approval for Kisunla, a new Alzheimer’s treatment that targets early symptomatic stages
Eli Lilly wins EU approval for Kisunla, a once-monthly Alzheimer’s therapy that slows decline and reshapes Europe’s treatment landscape.
Cayman Chemical partners with Akadeum Life Sciences to expand access to next-generation cell isolation technology
Cayman Chemical partners with Akadeum Life Sciences to expand global access to microbubble cell isolation kits, accelerating cell and gene therapy innovation.
Apiject seeks FDA approval for prefilled single-dose injection device using blow-fill-seal technology
Apiject files for FDA approval of its BFS-based prefilled injection device, aiming to cut costs, reduce foreign reliance, and reshape global drug delivery.
Eli Lilly wins FDA approval for Inluriyo in ESR1-mutated metastatic breast cancer
FDA approves Eli Lilly’s Inluriyo for ESR1-mutated breast cancer, boosting oncology pipeline and investor confidence. Learn how this reshapes treatment.
Axon Therapies just landed $32mn and a new CEO—can an implant-free heart failure therapy really change the game?
Find out how Axon Therapies’ $32M Series A and new CEO could speed implant-free heart failure trials and European expansion—see what it means for patients.
Is pharma nationalism reshaping global R&D? What GSK, Eli Lilly, and AstraZeneca are signaling to the world
GSK, Eli Lilly and AstraZeneca are reshaping global pharma strategy with massive U.S. investments—find out what this means for R&D, supply chains, and policy.
Investors eye KalVista’s $125m debt raise—Can EKTERLY commercialization justify the premium terms?
KalVista raises $125M through convertible notes due 2031 to fund EKTERLY commercialization. Find out what this financing means for biotech investors.
Mifepristone under fire: RFK Jr. orders FDA review of abortion pill used in most U.S. procedures
RFK Jr. orders FDA review of mifepristone, the abortion pill used in two-thirds of U.S. abortions. Explore the stakes for access, politics, and regulatory integrity.
Recce Pharmaceuticals stock rises as Phase 3 trial begins in Indonesia: Can RCE prove its anti-infective breakthrough?
Recce Pharmaceuticals (ASX:RCE) stock gained as it began a Phase 3 trial in Indonesia for diabetic foot infections. Explore what this means for investors and AMR.
Imlifidase clears pivotal US Phase 3 trial with strong kidney transplant results as Hansa Biopharma eyes FDA filing
Hansa Biopharma’s Imlifidase meets its Phase 3 trial endpoint in US kidney transplantation, setting up FDA filing and reshaping biotech investor sentiment.